Skip to main content

Advertisement

SpringerLink
Log in

Zoledronic acid-loaded bone cement as a local adjuvant therapy for giant cell tumor of the sacrum after intralesional curettage

  • Original Article
  • Published:
European Spine Journal Aims and scope Submit manuscript

Abstract

Purpose

Giant cell tumor of the sacrum is usually silent in initial stages and not diagnosed until achieving a large size. Intralesional curettage of the tumor has lower risk of neurological damage but is with high recurrence rate. Zoledronic acid-loaded cement was demonstrated to have cytotoxic effect on the cell line of giant cell tumor. This study evaluate if zoledronic acid-loaded bone cement would reduce the recurrence rate of sacral giant cell tumor after intralesional curettage.

Methods

Four patients were diagnosed as sacral giant cell tumor and received intralesional curettage with placement of zoledronic acid-loaded bone cement for adjuvant local control. The clinical records including tumor location, tumor size, complication, follow-up status, and functional outcome were analyzed retrospectively.

Results

All four patients presented with cauda equina syndrome before surgery with mean tumor volume of 472.8 cm3. With placement of zoledronic acid-loaded cement, no local recurrence was observed during the mean follow-up period of 28 months. All patients were found to have new bone regeneration on radiograph. All patients suffering from cauda equina syndrome were recovered.

Conclusions

We suggested that placement of zoledronic acid-loaded bone cement was an effective adjuvant therapy for sacral giant cell tumor following intralesional curettage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Szendroi M (2004) Giant-cell tumour of bone. J Bone Jt Surg Br 86(1):5–12

    CAS  Google Scholar 

  2. Martin C, McCarthy EF (2010) Giant cell tumor of the sacrum and spine: series of 23 cases and a review of the literature. Iowa Orthop J 30:69–75

    PubMed Central  PubMed  Google Scholar 

  3. Bloem JL, Reidsma II (2012) Bone and soft tissue tumors of hip and pelvis. Eur J Radiol 81(12):3793–3801. doi:10.1016/j.ejrad.2011.03.101

    Article  PubMed  Google Scholar 

  4. Leggon RE, Zlotecki R, Reith J, Scarborough MT (2004) Giant cell tumor of the pelvis and sacrum: 17 cases and analysis of the literature. Clin Orthop Relat Res 423:196–207

    Article  PubMed  Google Scholar 

  5. Marcove RC, Sheth DS, Brien EW, Huvos AG, Healey JH (1994) Conservative surgery for giant cell tumors of the sacrum. The role of cryosurgery as a supplement to curettage and partial excision. Cancer 74(4):1253–1260

    Article  CAS  PubMed  Google Scholar 

  6. Althausen PL, Schneider PD, Bold RJ, Gupta MC, Goodnight JE Jr, Khatri VP (2002) Multimodality management of a giant cell tumor arising in the proximal sacrum: case report. Spine 27(15):E361–E365

    Article  PubMed  Google Scholar 

  7. Qin LF, Peng D, Qin LH, Xu M, Fang H, Zhang Q (2014) Huge giant cell tumor of the sacrum: a case report. Oncol Lett 7(3):894–896. doi:10.3892/ol.2014.1812

    PubMed Central  PubMed  Google Scholar 

  8. Wei F, Liu X, Liu Z, Jiang L, Dang G, Ma Q, Dang L (2010) Interferon alfa-2b for recurrent and metastatic giant cell tumor of the spine: report of two cases. Spine 35(24):E1418–E1422. doi:10.1097/BRS.0b013e3181e7bf5a

    Article  PubMed  Google Scholar 

  9. Guo W, Ji T, Tang X, Yang Y (2009) Outcome of conservative surgery for giant cell tumor of the sacrum. Spine 34(10):1025–1031. doi:10.1097/BRS.0b013e31819d4127

    Article  PubMed  Google Scholar 

  10. Gille O, Oliveira Bde A, Guerin P, Lepreux S, Richez C, Vital JM (2012) Regression of giant cell tumor of the cervical spine with bisphosphonate as single therapy. Spine 37(6):E396–E399. doi:10.1097/BRS.0b013e31823ed70d

    Article  PubMed  Google Scholar 

  11. Tse LF, Wong KC, Kumta SM, Huang L, Chow TC, Griffith JF (2008) Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study. Bone 42(1):68–73. doi:10.1016/j.bone.2007.08.038

    Article  CAS  PubMed  Google Scholar 

  12. Nishisho T, Hanaoka N, Endo K, Takahashi M, Yasui N (2011) Locally administered zoledronic Acid therapy for giant cell tumor of bone. Orthopedics 34(7):e312–e315. doi:10.3928/01477447-20110526-22

    PubMed  Google Scholar 

  13. Zwolak P, Manivel JC, Jasinski P, Kirstein MN, Dudek AZ, Fisher J, Cheng EY (2010) Cytotoxic effect of zoledronic acid-loaded bone cement on giant cell tumor, multiple myeloma, and renal cell carcinoma cell lines. J Bone Jt Surg Am 92(1):162–168. doi:10.2106/JBJS.H.01679

    Article  Google Scholar 

  14. Wuisman P, Lieshout O, Sugihara S, van Dijk M (2000) Total sacrectomy and reconstruction: oncologic and functional outcome. Clin Orthop Relat Res 381:192–203

    Article  PubMed  Google Scholar 

  15. Ng VY, Davidson DJ, Kim EY, Pollack SM, Conrad Iii EU, Jones RL (2014) The multidisciplinary management of giant cell tumor of bone. Expert Rev Anticancer Ther 14(7):783–790. doi:10.1586/14737140.2014.901891

    Article  CAS  PubMed  Google Scholar 

  16. Ruggieri P, Mavrogenis AF, Ussia G, Angelini A, Papagelopoulos PJ, Mercuri M (2010) Recurrence after and complications associated with adjuvant treatments for sacral giant cell tumor. Clin Orthop Relat Res 468(11):2954–2961. doi:10.1007/s11999-010-1448-8

    Article  PubMed Central  PubMed  Google Scholar 

  17. Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res Off J Am Soc Bone Miner Res 10(10):1478–1487. doi:10.1002/jbmr.5650101008

    Article  CAS  Google Scholar 

  18. Cheng YY, Huang L, Lee KM, Xu JK, Zheng MH, Kumta SM (2004) Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone. Calcif Tissue Int 75(1):71–77. doi:10.1007/s00223-004-0120-2

    Article  CAS  PubMed  Google Scholar 

  19. Weiss HM, Pfaar U, Schweitzer A, Wiegand H, Skerjanec A, Schran H (2008) Biodistribution and plasma protein binding of zoledronic acid. Drug Metab Dispos Biol Fate Chem 36(10):2043–2049. doi:10.1124/dmd.108.021071

    Article  CAS  PubMed  Google Scholar 

  20. Marks KE, Nelson CL, Lautenschlager EP (1976) Antibiotic-impregnated acrylic bone cement. J Bone Jt Surg Am 58(3):358–364

    CAS  Google Scholar 

  21. Moojen DJ, Hentenaar B, Charles Vogely H, Verbout AJ, Castelein RM, Dhert WJ (2008) In vitro release of antibiotics from commercial PMMA beads and articulating hip spacers. J Arthroplast 23(8):1152–1156. doi:10.1016/j.arth.2007.08.020

    Article  Google Scholar 

  22. Kivioja AH, Blomqvist C, Hietaniemi K, Trovik C, Walloe A, Bauer HC, Jorgensen PH, Bergh P, Folleras G (2008) Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop 79(1):86–93. doi:10.1080/17453670710014815

    Article  PubMed  Google Scholar 

  23. Puri A, Agarwal M (2007) Treatment of giant cell tumor of bone: current concepts. Indian J Orthop 41(2):101–108. doi:10.4103/0019-5413.32039

    Article  PubMed Central  PubMed  Google Scholar 

  24. Arpornchayanon O, Leerapun T (2008) Effectiveness of intravenous bisphosphonate in treatment of giant cell tumor: a case report and review of the literature. J Med Assoc Thail Chotmaihet Thangphaet 91(10):1609–1612

    Google Scholar 

  25. Chaudhary P, Khadim H, Gajra A, Damron T, Shah C (2011) Bisphosphonate therapy is effective in the treatment of sacral giant cell tumor. Onkologie 34(12):702–704. doi:10.1159/000334549

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Orthopaedics and Traumatology, Taipei Veterans General Hospital, No 201, Sec 2, Shipai Rd, Beitou District, Taipei, 11217, Taiwan, ROC

    Kun-Hui Chen, Po-Kuei Wu, Cheng-Fong Chen & Wei-Ming Chen

  2. School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC

    Kun-Hui Chen, Po-Kuei Wu, Cheng-Fong Chen & Wei-Ming Chen

Authors
  1. Kun-Hui Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Po-Kuei Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cheng-Fong Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wei-Ming Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wei-Ming Chen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, KH., Wu, PK., Chen, CF. et al. Zoledronic acid-loaded bone cement as a local adjuvant therapy for giant cell tumor of the sacrum after intralesional curettage. Eur Spine J 24, 2182–2188 (2015). https://doi.org/10.1007/s00586-015-3978-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00586-015-3978-y

Keywords

Search

Navigation